JAMES HEALY Insider Trading $CHRS Coherus BioSciences, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JAMES HEALY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES HEALY. JAMES HEALY is Director in AMARIN CORP PLC\UK ($AMRN) and Director in INTERMUNE INC ($ITMN) and Director in HYPERION THERAPEUTICS INC ($HPTX) and Director in Edge Therapeutics, Inc. ($EDGE) and Director in Coherus BioSciences, Inc. ($CHRS) and Director in Bolt Biotherapeutics, Inc. ($BOLT) and in Natera, Inc. ($NTRA) and Director in Natera, Inc. ($NTRA) and Director in Iterum Therapeutics plc ($ITRM) and Director in Y-mAbs Therapeutics, Inc. ($YMAB) and in Karuna Therapeutics, Inc. ($KRTX) and Director in Karuna Therapeutics, Inc. ($KRTX).
JAMES HEALY in Coherus BioSciences, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JAMES HEALY: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 13 2021
$CHRS Market Capitalization: $1.03B
$CHRS Previous Close: $26.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JAMES HEALY in Coherus BioSciences, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMRN, BOLT, CHRS, HPTX, ITMN, ITRM, KRTX, NTRA, EDGE, YMAB
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 13 2021 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | A | 17.58 | 20,000 | 351,600 | 20,000 | |
| Oct 01 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | J | 0.00 | 213,546 | 0 | 434,555 | 221 K to 434.6 K (+96.62 %) |
| Oct 01 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Sell | J | 0.00 | 950,000 | 0 | 0 | 950 K to 0 (-100.00 %) |
| Oct 01 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | J | 0.00 | 213,546 | 0 | 434,555 | 221 K to 434.6 K (+96.62 %) |
| Oct 01 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Sell | J | 0.00 | 950,000 | 0 | 0 | 950 K to 0 (-100.00 %) |
| Sep 01 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | J | 0.00 | 221,009 | 0 | 221,009 | 0 to 221 K |
| Sep 01 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Sell | J | 0.00 | 983,221 | 0 | 950,000 | 1.9 M to 950 K (-50.86 %) |
| Jan 14 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | A | 17.73 | 20,000 | 354,600 | 20,000 | |
| Jan 13 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | M | 12.37 | 20,000 | 247,400 | 0 | |
| Jan 13 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | M | 10.05 | 20,000 | 201,000 | 0 | |
| Jan 13 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | M | 1.67 | 29,994 | 50,000 | 0 | |
| Jan 13 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | M | 12.37 | 20,000 | 247,400 | 70,086 | 50.1 K to 70.1 K (+39.93 %) |
| Jan 13 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | M | 10.05 | 20,000 | 201,000 | 50,086 | 30.1 K to 50.1 K (+66.48 %) |
| Jan 13 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | M | 1.67 | 29,994 | 50,000 | 30,086 | 92 to 30.1 K (+32,602.17 %) |
| Jul 02 2019 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Sell | S | 22.61 | 160,000 | 3,617,600 | 1,933,221 | 2.1 M to 1.9 M (-7.64 %) |
| Jul 02 2019 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Sell | S | 22.05 | 200,000 | 4,410,000 | 2,093,221 | 2.3 M to 2.1 M (-8.72 %) |
| Jun 24 2019 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Sell | S | 21.37 | 317,130 | 6,777,068 | 2,293,221 | 2.6 M to 2.3 M (-12.15 %) |
| May 24 2019 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Sell | S | 20.69 | 257,870 | 5,335,330 | 2,610,351 | 2.9 M to 2.6 M (-8.99 %) |
| Jan 30 2019 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | A | 12.37 | 20,000 | 247,400 | 20,000 | |
| Aug 31 2018 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Sell | S | 20.50 | 25,000 | 512,500 | 2,868,221 | 2.9 M to 2.9 M (-0.86 %) |
| Feb 05 2018 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | A | 10.05 | 20,000 | 201,000 | 20,000 | |
| May 26 2016 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | A | 18.28 | 10,000 | 182,800 | 10,000 | |
| Apr 03 2015 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | A | 29.00 | 25,000 | 725,000 | 25,000 | |
| Apr 03 2015 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | A | 29.00 | 20,000 | 580,000 | 20,000 | |
| Apr 03 2015 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | J | 0.00 | 239,364 | 0 | 2,893,221 | 2.7 M to 2.9 M (+9.02 %) |
| Apr 03 2015 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | J | 0.00 | 96,098 | 0 | 2,653,857 | 2.6 M to 2.7 M (+3.76 %) |
| Apr 03 2015 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | J | 0.00 | 33 | 0 | 92 | 59 to 92 (+55.93 %) |
| Apr 03 2015 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | J | 0.00 | 12 | 0 | 59 | 47 to 59 (+25.53 %) |
Page: 1